Reverse T-stenting and Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSan Luigi Gonzaga Hospital

About this trial

The Reverse T-stenting And Minimal Protrusion (Reverse TAP) is an up-front 2-stent technique that treats complex coronary bifurcation. Compared to crush techniques, it does not require crushing of the side branch stent but only minimal protrusion of the side branch stent before main vessel stenting. Nowadays, no studies compare the Reverse-TAP and the External Minicrush in treating complex coronary bifurcation, so eventually, procedural, clinical and safety differences remain unknown.

Eligibility criteria

Qualifiers

Patients >18 years old;

Patients with an indication of PCI, including Chronic Coronary syndrome (CCS) and Acute Coronary Syndrome (ACS), according to current guidelines recommendations; According to Medina and Definition criteria, patients with at least true and complex coronary lesions involved in coronary bifurcation.

Disqualifiers

Patients that refused informed consent;

Patients without valid vascular access that could make unsafe PCI;

Patients with an expected life of less than one year;

Patients with scheduled major surgery that required prolonged DAPT interruption;

Trial design

Treatments tested in this trial

  • Percutaneous Coronary Intervention

Treatment groups

361 Participants
are divided into 2 treatment groups

Sponsors and collaborators